Wockhardt Stock Screener | Share Price & Fundamental Analysis
WOCKPHARMA
Pharmaceuticals
Screen Wockhardt share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹1512.00
▲
46.30 (3.16%)
Share Price BSE
₹1512.50
▲
47.60 (3.25%)
Market Cap
₹22,329.67 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
5.07
EPS (TTM)
₹-3.02
Dividend Yield
-
Debt to Equity
0.57
52W High
₹1831.10
52W Low
₹1155.50
Operating Margin
23.00%
Profit Margin
10.21%
Revenue (TTM)
₹803.00
EBITDA
₹199.00
Net Income
₹82.00
Total Assets
₹8,135.00
Total Equity
₹4,657.00
Wockhardt Share Price History - Stock Screener Chart
Screen WOCKPHARMA historical share price movements with interactive charts. Analyze price trends and patterns.
Wockhardt Company Profile - Fundamental Screener
Screen Wockhardt company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for WOCKPHARMA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE049B01025
Wockhardt Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen WOCKPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 8,135 | 7,649 | 7,683 | 8,243 | 7,774 | 8,179 | 7,844 | 8,162 | 9,022 | 8,121 |
| Current Assets | 2,465 | 2,073 | 2,208 | 2,589 | 2,425 | 2,430 | 2,815 | 3,380 | 4,535 | 3,952 |
| Fixed Assets | 2,736 | 2,881 | 3,042 | 3,462 | 3,343 | 3,502 | 3,058 | 2,888 | 2,773 | 2,809 |
| Liabilities | ||||||||||
| Total Liabilities | 8,135 | 7,649 | 7,683 | 8,243 | 7,774 | 8,179 | 7,844 | 8,162 | 9,022 | 8,121 |
| Current Liabilities | 1,436 | 1,196 | 586 | 834 | 894 | 1,624 | 1,976 | 2,272 | 3,324 | 2,039 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 4,657 | 3,662 | 3,662 | 4,202 | 3,759 | 3,058 | 3,005 | 3,198 | 3,719 | 4,241 |
| Share Capital | 81 | 77 | 72 | 72 | 55 | 55 | 55 | 55 | 55 | 55 |
| Reserves & Surplus | 4,272 | 3,282 | 3,282 | 3,777 | 3,321 | 2,616 | 2,620 | 2,797 | 3,281 | 3,720 |
Screen WOCKPHARMA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 803 | 758 | 758 | 729 | 818 | 769 | 754 | 709 | 777 | 658 | 710 | 701 | 736 | 652 | 669 |
| Expenses | 604 | 763 | 679 | 593 | 699 | 648 | 803 | 664 | 681 | 642 | 771 | 657 | 831 | 611 | 871 |
| EBITDA | 199 | -5 | 79 | 136 | 119 | 121 | -49 | 45 | 96 | 16 | -61 | 44 | -95 | 41 | -202 |
| Operating Profit % | 23.00% | -3.00% | 9.00% | 18.00% | 14.00% | 12.00% | -15.00% | 5.00% | 10.00% | 0.00% | -14.00% | 6.00% | -22.00% | -3.00% | -33.00% |
| Depreciation | 53 | 56 | 53 | 55 | 55 | 54 | 58 | 55 | 55 | 55 | 56 | 66 | 65 | 64 | 59 |
| Interest | 55 | 48 | 48 | 60 | 73 | 73 | 73 | 77 | 76 | 79 | 76 | 83 | 70 | 73 | 86 |
| Profit Before Tax | 91 | -109 | -22 | 21 | -9 | -6 | -180 | -87 | -35 | -118 | -193 | -105 | -230 | -96 | -347 |
| Tax | 9 | -1 | 23 | 1 | 7 | 10 | -3 | -1 | 38 | 18 | 44 | -3 | -23 | -21 | -36 |
| Net Profit | 82 | -108 | -45 | 20 | -16 | -16 | -177 | -86 | -73 | -136 | -237 | -102 | -207 | -75 | -311 |
| EPS | 4.81 | -5.53 | -1.57 | 0.91 | -1.47 | -0.95 | -11.64 | -5.75 | -5.37 | -9.28 | -14.37 | -6.62 | -13.15 | -4.64 | -21.20 |
Wockhardt Cash Flow Screener - Liquidity Fundamentals
Screen WOCKPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -22 | 219 | 153 | 413 | -287 | 649 | 183 | 68 | -270 | -42 |
| Investing Activities | -780 | -138 | -118 | -204 | 1,471 | -147 | 93 | 635 | -684 | -106 |
| Financing Activities | 409 | 334 | -315 | -71 | -1,171 | -680 | -777 | -770 | 1,255 | 193 |
| Net Cash Flow | -393 | 415 | -280 | 138 | 13 | -178 | -500 | -66 | 301 | 46 |
Screen WOCKPHARMA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Nov | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 49.09% | 49.09% | 49.08% | 51.60% | 51.99% | 51.99% | 49.09% | 49.09% |
| FII Holding | 6.81% | 7.29% | 7.10% | 5.49% | 5.93% | 6.70% | 6.62% | 6.54% |
| DII Holding | 10.59% | 11.01% | 11.01% | 4.83% | 4.45% | 5.09% | 9.88% | 9.82% |
| Govt Holding | 0.02% | 0.02% | 0.02% | 0.01% | 0.01% | 0.02% | 0.02% | 0.02% |
| Public Holding | 26.69% | 26.05% | 26.10% | 29.94% | 30.18% | 29.02% | 27.45% | 27.49% |
| Other Holding | 6.80% | 6.55% | 6.69% | 8.13% | 7.43% | 7.19% | 6.95% | 7.04% |
| Shareholder Count | 141,799 | 146,918 | 137,946 | 146,376 | 140,391 | 138,142 | 143,876 | 142,710 |
Wockhardt Dividend Screener - Share Yield Analysis
Screen WOCKPHARMA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹10.00 | 1.49% |
| 2016-March | ₹0.00 | 0.00% |
Wockhardt Index Membership - Market Screener Classification
Screen WOCKPHARMA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Wockhardt Market Events Screener - Corporate Actions
Screen WOCKPHARMA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-03 | 2025-11-03 | Quarterly Result Announcement | NA | -1.20% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -8.71% |
| 2025-08-08 | 2025-08-08 | Annual General Meeting | NA | -16.82% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 1.49% |
| 2025-02-07 | 2025-02-07 | Quarterly Result Announcement | NA | 5.96% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -2.06% |
| 2024-06-28 | 2024-06-28 | Annual General Meeting | NA | 27.23% |
| 2022-03-08 | 2022-03-09 | Rights | 3:10 | -1.19% |
Wockhardt Competitors Screener - Peer Comparison
Screen WOCKPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,734 | 39.30 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 168,851 | 68.25 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 129,357 | 59.98 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 120,557 | 22.21 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 105,645 | 18.46 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 95,023 | 21.85 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 90,707 | 18.09 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 88,846 | 50.78 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 68,901 | 20.36 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,390 | 27.28 | 13,458 | 3.70% | 2,216 | 37.45 |
Wockhardt Company Announcements - News Screener
Screen WOCKPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-07 | Closure of Trading Window | View |
| 2025-12-16 | Intimation For Incorporation Of Step-Down Subsidiaries Of The Company. | View |
| 2025-12-15 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-12-15 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-12-02 | Reply To Email Related To Volume Movement | View |
| 2025-12-02 | Clarification sought from Wockhardt Ltd | - |
| 2025-12-01 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-11-04 | Reply To Your Email Dated 4Th November 2025 Relating To Volume Movement | View |
| 2025-11-04 | Clarification sought from Wockhardt Ltd | - |
| 2025-11-03 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2025-11-03 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-03 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-03 | Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-03 | Board Meeting Outcome for Outcome Of The Board Meeting | View |
| 2025-10-29 | Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited ( The Company). | View |
| 2025-10-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |